Paper3935203
Clinical trial of berberine in acute watery diarrhoea.
Khin-Maung-U and 4 others. Br Med J (Clin Res Ed), 1985. Cited by 47 papers, by iCite.
Cite this record
ConductScience Library. Clinical trial of berberine in acute watery diarrhoea. Papers, record 3935203. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3935203
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Berberine | Major topic |
| Berberine Alkaloids | Major topic |
| Diarrhea | Major topic |
| Acute Disease | |
| Adult | |
| Cholera | |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Male | |
| Random Allocation | |
| Tetracycline |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4293678 | Effect of berberine sulphate on Entamoeba histolytica. | Nature | 1967 | https://conductscience.org/library/papers/4293678 | PubMed |
| 2 | 5595636 | Vibriostatic action of berberine. | Indian J Pathol Bacteriol | 1967 | https://conductscience.org/library/papers/5595636 | PubMed |
| 3 | 4906191 | Berberine sulfate: antimicrobial activity, bioassay, and mode of action. | Can J Microbiol | 1969 | https://conductscience.org/library/papers/4906191 | PubMed |
| 4 | 5506208 | Presidential address: 7th National Conference of the Indian Academy of Pediatrics. | Indian Pediatr | 1970 | https://conductscience.org/library/papers/5506208 | PubMed |
| 5 | 5131809 | Berberine in treatment of diarrhoea. | Indian Pediatr | 1971 | https://conductscience.org/library/papers/5131809 | PubMed |
| 6 | 4656981 | Kala-azar in Gujarat. | J Indian Med Assoc | 1972 | https://conductscience.org/library/papers/4656981 | PubMed |
| 7 | 14090856 | TETRACYCLINE IN THE TREATMENT OF CHOLERA. | Lancet | 1964 | https://conductscience.org/library/papers/14090856 | PubMed |
| 8 | 863481 | Anti-inflammatory effect of berberine in rats injected locally with cholera toxin. | Indian J Med Res | 1977 | https://conductscience.org/library/papers/863481 | PubMed |
| 9 | 924544 | Antagonism of cholera toxin by berberine in the gastrointestinal tract of adult rats. | Indian J Med Res | 1977 | https://conductscience.org/library/papers/924544 | PubMed |
| 10 | 84263 | Chlorpromazine reduces fluid-loss in cholera. | Lancet | 1979 | https://conductscience.org/library/papers/84263 | PubMed |
| 11 | 521094 | Possible mechanism of antidiarrhoeal effect of berberine. | Indian J Med Res | 1979 | https://conductscience.org/library/papers/521094 | PubMed |
| 12 | 7282933 | Reversal of cholera toxin-induced secretion in rat ileum by luminal berberine. | Am J Physiol | 1981 | https://conductscience.org/library/papers/7282933 | PubMed |
| 13 | 7035365 | Berberine inhibits intestinal secretory response of Vibrio cholerae and Escherichia coli enterotoxins. | Infect Immun | 1982 | https://conductscience.org/library/papers/7035365 | PubMed |
| 14 | 1096596 | Use of berberine in treatment of giardiasis. | Am J Dis Child | 1975 | https://conductscience.org/library/papers/1096596 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41716830 | Protective impacts of berberine in weaned piglets fed without zinc oxide: Insight of jejunal barrier function, water absorption, and gut microbiota and metabolism. | Anim Nutr | 2026 | https://conductscience.org/library/papers/41716830 | PubMed |
| 38892226 | Evaluation of In Vitro Synergistic Effects of Tetracycline with Alkaloid-Related Compounds against Diarrhoeic Bacteria. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38892226 | PubMed |
| 36839605 | Plant-Derived Products with Therapeutic Potential against Gastrointestinal Bacteria. | Pathogens | 2023 | https://conductscience.org/library/papers/36839605 | PubMed |
| 35745691 | Evaluation of the Cytotoxic Activity and Anti-Migratory Effect of Berberine-Phytantriol Liquid Crystalline Nanoparticle Formulation on Non-Small-Cell Lung Cancer In Vitro. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35745691 | PubMed |
| 34793441 | A Phase 2a randomized, single-center, double-blind, placebo-controlled study to evaluate the safety and preliminary efficacy of oral iOWH032 against cholera diarrhea in a controlled human infection model. | PLoS Negl Trop Dis | 2021 | https://conductscience.org/library/papers/34793441 | PubMed |
| 34572626 | Phytochemicals: A Promising Weapon in the Arsenal against Antibiotic-Resistant Bacteria. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/34572626 | PubMed |
| 34220777 | Antibacterial Activity of a Fractionated Pistacia lentiscus Oil Against Pharyngeal and Ear Pathogens, Alone or in Combination With Antibiotics. | Front Microbiol | 2021 | https://conductscience.org/library/papers/34220777 | PubMed |
| 33149763 | Berberine for diarrhea in children and adults: a systematic review and meta-analysis. | Ther Adv Gastroenterol | 2020 | https://conductscience.org/library/papers/33149763 | PubMed |
| 31988653 | The status of and trends in the pharmacology of berberine: a bibliometric review [1985-2018]. | Chin Med | 2020 | https://conductscience.org/library/papers/31988653 | PubMed |
| 29676231 | Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential. | Curr Neuropharmacol | 2019 | https://conductscience.org/library/papers/29676231 | PubMed |
| 28839371 | Berberine Depresses Contraction of Smooth Muscle via Inhibiting Myosin Light-chain Kinase. | Pharmacogn Mag | 2017 | https://conductscience.org/library/papers/28839371 | PubMed |
| 25279787 | Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula. | ISME J | 2015 | https://conductscience.org/library/papers/25279787 | PubMed |
| 21718555 | Diarrhoea in adults (acute). | BMJ Clin Evid | 2011 | https://conductscience.org/library/papers/21718555 | PubMed |
| 19450323 | Diarrhoea in adults (acute). | BMJ Clin Evid | 2008 | https://conductscience.org/library/papers/19450323 | PubMed |
| 10560294 | Adverse reactions to watch for in patients using herbal remedies. | West J Med | 1999 | https://conductscience.org/library/papers/10560294 | PubMed |
| 10150156 | Pharmacoeconomics of the therapy of diarrhoeal disease. | Pharmacoeconomics | 1992 | https://conductscience.org/library/papers/10150156 | PubMed |
| 3069441 | Current management of acute diarrhoeas. Use and abuse of drug therapy. | Drugs | 1988 | https://conductscience.org/library/papers/3069441 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3935203
GET https://conductscience.org/api/papers/v1/3935203/authors